AI tool to improve eye test accuracy in glaucoma patients
Part of Eyes & vision clinical trials.
This trial tests if a large language model tool can help patients perform more reliable visual field tests. It may improve detection of glaucoma progression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have glaucoma or are suspected of having it
- You speak English
- You are scheduled for a Humphrey visual field test
- You have had at least 2 prior visual field tests, with the most recent one using the 24-2 SITA Standard method within the last 2 years
- Your best corrected vision is 20/40 or better in both eyes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a large language model (an AI tool) can help explain intraocular lens options to patients before cataract surgery. If you're planning your first cataract surgery, you may be able to join.
This study looks at different ways to measure how glaucoma affects your vision over time by comparing visual field results. It may help researchers find better models to track progression so treatment decisions can be made more accurately.
This trial tests an artificial intelligence tool that may help detect glaucoma earlier. It compares AI analysis of eye images between people with glaucoma and healthy volunteers.
This pilot study tests a new portable device for measuring your field of vision during a glaucoma clinic visit. You may benefit from a quicker or more convenient test.
This trial compares different visual field test patterns to detect central vision loss in glaucoma patients who already show thinning of retinal cells. The goal is to find which test pattern works best for early detection.
This study is testing an artificial intelligence tool that can automatically detect signs of glaucoma in photos of the retina. It may help confirm that the AI can accurately identify glaucoma, which could lead to faster diagnosis and monitoring for patients.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.